Study aim. Short telomeres forming as a result of double-stranded DNA breaks and under-replication cause arrest of the cell cycle, leading to cell senescence and death. Telomere erosion is an important mechanism regulating the aging process, limiting cell proliferation. Many studies in telomere biology in recent decades have shown that telomere DNA and telomere proteins are involved in the pathogenesis of various diseases in humans. The aim of the present work was to study telomere length in Parkinson’s disease (PD). Materials and methods. Telomere length was measured in buccal epithelial cells and leukocytes from patients with PD and a control group. Results and conclusions. Telomeres in buccal epithelial cells were found to be shorter in PD patients than in the control group; telomere lengths in blood cells were identical. It is suggested that telomere shortening in buccal epithelial cells may be due to oxidative stress and may therefore be used as a marker for PD at the early stages of disease.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
M. P. Longhese, “DNA damage response at functional and dysfunctional telomeres,” Genes Dev., 22, 125–140 (2008).
J. D. Griffith, L. Comeau, S. Rosenfeld, et al., “Mammalian telomeres end in a large duplex loop,” Cell, 97, 503–514 (1999).
T. de Lange, “Protection of mammalian telomeres,” Oncogene, 21, 532–540 (2002).
T. de Lange, “Shelterin: the protein complex that shapes and safeguards human telomeres,” Genes Dev., 19, 2100–2110 (2005).
C. J. Cairney and W. N. Keith, “Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity,” Biochimie, 90, 13–23 (2008).
Y. Zhao, A. J. Sfeir, Y. Zou, et al., “Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells,” Cell, 138, 463–475 (2009).
L. Hayflick, “The limited in vitro lifetime of human diploid cell strains,” Exp. Cell Res., 37, 614–636 (1965).
J. R. Mitchell, J. Cheng, and K. Collins, “A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3’ end,” Mol. Cell Biol., 19, 567–576 (1999).
A. Aviv, A. Valdes, J. P. Gardner, et al., “Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation,” J. Clin. Endocrinol. Metab., 91, 635–640 (2006).
T. von Zglinicki, “Oxidative stress shortens telomeres,” Trends Biochem. Sci., 27, 339–344 (2002).
R. W. Frenck, Jr., E. H. Blackburn, and K. M. Shannon, “The rate of telomere sequence loss in human leukocytes varies with age,” Proc. Natl. Acad. Sci. USA, 95, 5607–5610 (1998).
U. Friedrich, E. Gries, M. Schwab, et al., “Telomere length in different tissues of elderly patients,” Mech. Ageing Dev., 119, 89–99 (2000).
H. Vaziri, W. Dragowska, R. C. Allsop, et al., “Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age,” Proc. Natl. Acad. Sci. USA, 91, 9857–9860 (1994).
S. Brouilette, R. K. Singh, J. R. Thompson, et al., “Cell telomere length and risk of premature myocardial infarction,” Arterioscler. Thromb. Vasc. Biol., 23, 842–846 (2003).
M. Ogami, Y. Ikura, M. Ohsawa, et al., “Telomere shortening in human coronary artery diseases,” Arterioscler. Thromb. Vasc. Biol., 24, 546–550 (2004).
O. Uziel, J. A. Singer, V. Danicek, et al., “Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control,” Exp. Gerontol., 42, 971–978 (2007).
L. A. Panossian, V. R. Porter, H. F. Valenzuela, et al., “Telomere shortening in T cells correlates with Alzheimer’s disease status,” Neurobiol. Ageing, 24, 77–84 (2003).
A. M. Valdes, T. Andrew, J. P. Gardner, et al., “Obesity, cigarette smoking, and telomere length in women,” Lancet, 366, 662–664 (2005).
E. S. Epel, E. H. Blackburn, F. Lin, et al., “Accelerated telomere shortening in response to life stress,” Proc. Natl. Acad. Sci. USA, 101, 17312–17315 (2004).
R. M. Cawthon, “Telomere length measurement by a novel monochrome multiplex quantitative PCR method,” Nucl. Acids Res., 37, 21 (2009).
R. M. Cawthon, “Telomere measurement by quantitative PCR,” Nucl. Acids Res., 30, 47 (2002).
J. Z. Guan, T. Maeda, M. Sugano, et al., “A percentage analysis of the telomere length in Parkinson’s disease patients,” J. Gerontol. A. Biol. Sci. Med. Sci., 63, 467–473 (2008).
H. Wang, H. Chen, X. Gao, et al., “Telomere length and risk of Parkinson’s disease,” Mov. Disord., 23, 302–305 (2008).
T. Maeda, J. Z. Guan, J. Oyama, et al., “Aging-associated alteration of subtelomeric methylation in Parkinson’s disease,” J. Gerontol. A. Biol. Sci. Med. Sci., 64, 949–955 (2009).
P. Thomas, N. J. O’Callaghan, and M. Fenech, “Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer’s disease,” Mech. Ageing Dev., 129, 183–190 (2008).
C. Cipriano, S. Tesei, M. Malavolta, et al., “Accumulation of cells with short telomeres is associated with impaired zinc homeostasis and inflammation in old hypertensive participants,” J. Gerontol. A. Biol. Sci. Med. Sci., 64, 745–751 (2009).
P. Ilmonen, A. Kotrschal, and D. J. Penn, “Telomere attrition due to infection,” PLoS One, 3, 2143 (2008).
J. J. Carreo, P. Stenvinkel, B. Fellstrom, et al., “Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients,” J. Int. Med., 263, 302–312 (2008).
A. Aviv, “Telomeres and human aging: facts and fi bs,” Sci. Aging Knowl. Environ., 51, 43 (2004).
S. Kawanishi and O. Oikawa, “Mechanism of telomere shortening by oxidative stress,” Ann. NY Acad. Sci., 1019, 278–284 (2004).
N. Sitte, G. Saretzki, and T. von Zglinicki, “Accelerated telomere shortening in fibroblasts after extended periods of confluency,” Free Radic. Biol. Med., 24, 885–893 (1998).
T. von Zglinicki, C. Martin-Ruiz, and G. Saretzki, “Telomeres, cell senescence and human ageing,” Signal Transduct., 3, 103–114 (2005).
S. Petersen, G. Saretzki, and T. von Zglinicki, “Preferential accumulation of single-stranded regions in telomeres of human fibroblasts,” Exp. Cell Res., 239, 152–160 (1998).
T. Richter, G. Saretzki, G. Nelson, et al., “TRF2 overexpression diminishes repair of telomeric single-strand breaks and accelerates telomere shortening in human fibroblasts,” Mech. Ageing Dev., 128, 340–345 (2007).
O. Beyne-Rauzy, C. Recher, N. Sastugue, et al., “Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells,” Oncogene, 23, 7507–7516 (2004).
A. A. Boldyrev, “Oxidative stress and the brain,” Soros. Obraz. Zh., No. 4, 21–28 (2001).
K. M. Dyumaev, T. A. Voronina, and L. D. Smirnov, Antioxidants in the Prophylaxis and Treatment of CNS Pathology, Institute of Biomedical Chemistry Press, Russian Academy of Medical Sciences, Moscow (1995).
I. A. Zavalishina, N. N. Yakhno, and S. I. Gavrilova, Neurodege nerative Diseases and Aging, A.A.A., Moscow (2001).
K. Koziorowski and J. Jasztal, “Factors which can play important role in pathogenesis of Parkinson disease,” Neurol. Neurochir. Pol., 33, 907–921 (1999).
D. J. Moore, V. L. Dawson, and T. M. Sawson, “Molecular pathophysiology of Parkinson’s disease,” Annu. Rev. Neurosci., 28, 57–87 (2005).
B. Thomas and M. F. Beal, “Parkinson’s disease,” Hum. Mol. Genet., 16, 183–194 (2007).
J. R. Vaughan, M. J. Farrer, Z. K. Wszolek, et al., “Sequencing of the alphasynuclein gene in a large series of cases of familial Parkinson’s disease fails to reveal any further mutations,” Hum. Mol. Genet., 7, 751–753 (1998).
M. W. Fariss, C. B. Chan, M. Patel, et al., “Role of mitochondria in toxic oxidative stress,” Mol. Interv., 5, 94–111 (2005).
M. Naoi and W. Maruyama, “Cell death of dopamine neurons in aging and Parkinson’s disease,” Mech. Ageing Dev., 111, 175–188 (1999).
N. Ogawa and A. Mori, “Parkinson’s disease, dopamine and free radicals,” in: Oxidative Stress and Aging, R. G. Cutler (ed.), New York (1995), pp. 303–309.
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 114, No. 8, Iss. I, pp. 58–61, August, 2014.
About this article
Cite this article
Kolyada, A.K., Vaiserman, A.M., Krasnenkov, D.S. et al. Studies of Telomere Length in Patients with Parkinson’s Disease. Neurosci Behav Physi 46, 344–347 (2016). https://doi.org/10.1007/s11055-016-0239-4
- Parkinson’s disease
- telomere theory of aging